Financings

AcelRx Pharmaceuticals Inc. completed a $10 million private placement.

PhaseBio Pharmaceuticals Inc. received a third tranche of $23 million in its Series B financing.

Ceptaris Therapeutics Inc. raised $10 million through a Series D-1 private placement of preferred stock.

InnoPharma Inc. closed an $8 million financing from Comerica Bank and NXT Capital Venture Finance.

Deals

Merck Serono partnered with Dr. Reddy's Laboratories Ltd. to co-develop biosimilar cancer compounds.

MediGene AG sold a 2 percent royalty of Eligard to Cowen Healthcare Royalty Partners II for $17.7 million.

OPKO Health Inc. will take a 45 percent stake in a private Israeli company producing hepatitis B vaccine.

Oragenics Inc. and Intrexon Corp. will develop antibiotics used in treating infectious diseases.

. . . And More

See BioWorld Today for coverage of the American Society of Clinical Oncology annual meeting.

Talon Therapeutics Inc. dosed first patient in its Marqibo Phase III ALL Trial.

Marina Biotech Inc. furloughed 90 percent of its employees and ceased most day-to-day operations.

Xenoport Inc. received FDA approval of Horizant for postherpetic neuralgia, but its shares plunge almost 10 percent.